National Drug Threat Assessment
Author :
Publisher :
Page : 106 pages
File Size : 29,45 MB
Release : 2000
Category : Drug control
ISBN :
Author :
Publisher :
Page : 106 pages
File Size : 29,45 MB
Release : 2000
Category : Drug control
ISBN :
Author :
Publisher :
Page : pages
File Size : 23,4 MB
Release : 2002
Category : Drug control
ISBN :
Author : Barry Leonard
Publisher : DIANE Publishing
Page : 89 pages
File Size : 48,35 MB
Release : 2009-11
Category : Political Science
ISBN : 1437915655
This assessment by the National Drug Intelligence Center provides a strategic overview and predictive outlook of drug trafficking and abuse trends within the U.S. The assessment identifies the primary drug threats to the nation, tracks drug availability throughout the country, and analyzes trafficking and distribution patterns of illicit drugs within the U.S. It evaluates the threat posed by illegal drugs by examining availability, production and cultivation, transportation, distribution, and demand. Extensive maps, charts and tables.
Author : United States. Congress. House. Select Committee on Narcotics Abuse and Control
Publisher :
Page : 224 pages
File Size : 48,60 MB
Release : 1991
Category : Political Science
ISBN :
Author : Paul Ziegler
Publisher :
Page : 0 pages
File Size : 32,82 MB
Release : 2011
Category : Drug control
ISBN : 9781608760657
The global illegal drug trade represents a multi-dimensional challenge that has implications for U.S. national interests as well as the international community. According to the U.S. intelligence community, international drug trafficking can undermine political and regional stability and bolster the role and capabilities of organised crime in the drug trade. Key regions of concern include Latin American and Afghanistan, which are focal points in U.S. efforts to combat the production and transit of cocaine and heroin, respectively. Drug use and addiction have the potential to negatively affect the social fabric of communities, hinder economic development, and place an additional burden on national public health infrastructures. This book examines U.S. international drug control policy with a focus on the impact of drugs on society, drug trafficking organisations, and the global scope of the problem.
Author :
Publisher :
Page : 102 pages
File Size : 42,80 MB
Release : 2000
Category : Drug control
ISBN :
Author :
Publisher :
Page : 86 pages
File Size : 39,4 MB
Release : 2012
Category : Organized crime
ISBN :
This report is one of several studies conducted by UNODC on organized crime threats around the world. These studies describe what is known about the mechanics of contraband trafficking - the what, who, how, and how much of illicit flows - and discuss their potential impact on governance and development. Their primary role is diagnostic, but they also explore the implications of these findings for policy. Publisher's note.
Author : National Drug Intelligence Center (U.S.)
Publisher :
Page : pages
File Size : 15,58 MB
Release : 2003
Category : Drug control
ISBN :
Author : Mary Ellen O'Toole
Publisher : DIANE Publishing
Page : 52 pages
File Size : 10,3 MB
Release : 2009
Category :
ISBN : 1428996400
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 483 pages
File Size : 18,10 MB
Release : 2017-09-28
Category : Medical
ISBN : 0309459575
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.